Ezetimibe Patent Expiration
Ezetimibe is Used for lowering cholesterol levels in patients with primary hyperlipidemia. It was first introduced by Organon Llc A Sub Of Organon And Co
Ezetimibe Patents
Given below is the list of patents protecting Ezetimibe, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Zetia | US5846966 | Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors |
Sep 21, 2013
(Expired) | Organon |
| Zetia |
US5846966 (Pediatric) | Combinations of hydroxy-substituted azetidinone compounds and HMG CoA Reductase Inhibitors |
Mar 21, 2014
(Expired) | Organon |
| Zetia | US7030106 | Sterol absorption inhibitor compositions |
Jan 25, 2022
(Expired) | Organon |
| Zetia |
US7030106 (Pediatric) | Sterol absorption inhibitor compositions |
Jul 25, 2022
(Expired) | Organon |
| Zetia | US7612058 | Methods for inhibiting sterol absorption | Oct 30, 2025 | Organon |
| Zetia |
US7612058 (Pediatric) | Methods for inhibiting sterol absorption | Apr 30, 2026 | Organon |
| Zetia | USRE37721 | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
Oct 25, 2016
(Expired) | Organon |
| Zetia |
USRE37721 (Pediatric) | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
Apr 25, 2017
(Expired) | Organon |
| Zetia | USRE42461 | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
Oct 25, 2016
(Expired) | Organon |
| Zetia |
USRE42461 (Pediatric) | Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
Apr 25, 2017
(Expired) | Organon |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Ezetimibe's patents.
Latest Legal Activities on Ezetimibe's Patents
Given below is the list recent legal activities going on the following patents of Ezetimibe.
| Event | Date | Patent/Publication |
|---|---|---|
 | ||
| Correspondence Address Change | 10 Aug, 2021 | US7030106 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 15 Apr, 2021 | US7612058 |
| Payment of Maintenance Fee, 12th Year, Large Entity | 14 Sep, 2017 | US7030106 |
| Post Issue Communication - Certificate of Correction | 08 Jan, 2014 | US7612058 |
| Mail-Petition Decision - Granted | 21 Oct, 2013 | US7612058 |
| Adjustment of PTA Calculation by PTO | 21 Oct, 2013 | US7612058 |
| Petition Decision - Granted | 21 Oct, 2013 | US7612058 |
| Correspondence Address Change | 26 Aug, 2011 | US7030106 |
| Appellant's Complaint | 30 Apr, 2010 | US7612058 |
| Petition Entered | 22 Dec, 2009 | US7612058 |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Ezetimibe Generics
Several generic applications have been filed for Ezetimibe. The first generic version for Ezetimibe was by Glenmark Pharmaceuticals Ltd and was approved on Jun 26, 2015. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Apr 29, 2024.
Given below is the list of companies who have filed for Ezetimibe generic.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Oct 26, 2018 |
2. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Jun 12, 2017 |
3. RISING
Rising Pharma Holding Inc has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Rising.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Apr 26, 2019 |
4. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Apr 29, 2024 |
5. SANDOZ
Sandoz Inc has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Jun 12, 2017 |
6. HETERO LABS LTD III
Hetero Labs Ltd Unit Iii has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Jul 26, 2022 |
7. SCIEGEN PHARMS INC
Sciegen Pharmaceuticals Inc has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Oct 23, 2020 |
8. ORIENT PHARMA
Orient Pharma Co Ltd has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Orient Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Sep 13, 2022 |
9. OHM LABS INC
Ohm Laboratories Inc has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Ohm Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Jun 12, 2017 |
10. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Aug 25, 2017 |
11. ALKEM LABS LTD
Alkem Laboratories Ltd has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Dec 21, 2017 |
12. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Jun 12, 2017 |
13. APOTEX
Apotex Inc has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Apotex.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Discontinued | ORAL | N/A | Jun 12, 2017 |
14. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Jun 26, 2015 |
15. AMNEAL PHARMS CO
Amneal Pharmaceuticals Co Gmbh has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Amneal Pharms Co.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Jun 12, 2017 |
16. WATSON LABS INC
Watson Laboratories Inc has filed for 1 generic for Ezetimibe. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG | tablet | Prescription | ORAL | AB | Jun 12, 2017 |